Cooley appoints ‘first-rate’ life sciences partner trio
The ‘formidable’ three bring 52 years’ experience from Fish & Richardson collectively | ‘Extensive’ patent trial background includes branded Hatch-Waxman litigation.
Indivior avoids multi-state antitrust trial with $100m payout
Case involved the alleged monopolisation of an opioid addiction treatment | More than 40 attorneys general had filed complaints against the pharma company.
Abbott sues former employee for alleged trade secrets theft
Ex-scientist faces lawsuit for allegedly downloading thousands of files before leaving for a rival | Abbott seeks damages for ‘flagrant misconduct’ brought to its attention by successive employer.
‘A new dawn for patents’: the UPC opens its doors
A project decades in the making, the Unified Patent Court and Unitary Patent promise to change the European IP landscape, writes Marisa Woutersen.
Moderna and Pfizer face fresh suits over COVID-19 vaccine
A US biotech is accusing the pair of infringing several of its “foundational” lipid particle patents | Pfizer and BioNTech accused plaintiff in earlier suit of antitrust in a dispute over one of the patents at issue.
UPC releases contingency plan for hard copy opt-outs
Court outlines submission method in the event of CMS failure | Hard-copy format requirements include USB stick and delivery to Luxembourg | Guidelines have “made people nervous” say lawyers | Full details on how to submit.
Split Fed Cir refutes Medtronic challenge to catheter patents
Medtronic prior art reference does not qualify, says Federal Circuit | Firm was hoping to invalidate five catheter technology patents.
J&J settles Amgen clash over blockbuster psoriasis drug
Amgen can market biosimilar version of Stelara from January 2025 | J&J had alleged infringement of two Stelara patents.
Novartis ‘abused’ discovery process for Zolgensma patent
Two subsidiaries of the French pharma giant allege ‘wilful’ patent infringement by the Swiss-American pharma firm | Novartis ‘hid’ information in a previous lawsuit relating to spinal muscular atrophy drug used to treat young children.
Sanofi wins enablement showdown at SCOTUS
Case concerned the interpretation of a key requirement of the US Patent Act | Amgen’s ‘roadmap’ held to describe step-by-step its own trial-and-error method for finding functional antibodies.